Company news
Pharma Foods International Co., Ltd. (TSE:2929) news
Pharma Foods International Co., Ltd. news releases on 6ix. Latest, Oct 6, 2026: Notice Regarding Acquisition of Shares of Marine Pro Foods Co., Ltd. (to Make…
Press releases & updates
Notice Regarding Acquisition of Shares of Marine Pro Foods Co., Ltd. (to Make It a Subsidiary)
October 6, 2026
Supplementary Materials of FY26 Q4 Consolidated Financial Results
September 28, 2026
【 Correction of Numerical Data】Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)
September 17, 2026
[Summary] Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)
September 11, 2026
Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ended July 2026
September 8, 2026
[Summary] Consolidated Financial Results for the Nine Months Ended April 30, 2026 (Under Japanese GAAP)
June 10, 2026
Pharma Foods International : April 30, 2026 Research and Development PharmaGABA® New Scientific Study Published in Leading International Journal - Accelerating Global Expansion and Adoption in the Food & Beverage Category
April 29, 2026
Pharma Foods International : April 6, 2026 Research and Development Pharma Foods Co., Ltd. Acquires Exclusive Rights to Advance First-in-Class Adrenomedullin Program for CADASIL Across Key Asian Markets
April 5, 2026
Pharma Foods International : March 23, 2026 Investor Supplementary Materials of Consolidated Financial Results for the Six Months Ended January 31, 2026
March 23, 2026
Pharma Foods International : February 16, 2026 Investor Notice Concerning Dividends of Surplus (Interim Dividend)
February 16, 2026
Pharma Foods International : December 11, 2025 Investor Supplementary Materials of Consolidated Financial Results for the Three Months Ended October 31 2025
December 10, 2025
Pharma Foods International : December 11, 2025 Investor Consolidated Financial Results for the Three Months Ended October 31, 2025 (Under Japanese GAAP)
December 10, 2025
Pharma Foods International : November 13, 2025 Research and Development Pharma Foods Partners with The University of Tokyo For Next-Generation Antibody Drug Discovery ～A Leap Forward with AI and Advanced Molecular Engineering～
November 12, 2025
Pharma Foods International : September 30, 2025 Investor Notice of the 28th Annual General Meeting of Shareholders
September 29, 2025
Pharma Foods International : September 25, 2025 Investor Consolidated Financial Results for the Year Ended July 31, 2025 (Based on Japanese GAAP)
September 25, 2025
Pharma Foods International : September 24, 2025 Research and Development “ALAgene® technology”-Derived Antibody Therapeutic Candidate Achieves Phase I Clinical Milestone ～Driving Future Growth through Strategic License Agreement～
September 24, 2025
Pharma Foods International : September 19, 2025 Investor Notice Regarding the Board of Directors’ Opinion on a Shareholder Proposal
September 19, 2025
Pharma Foods International : September 19, 2025 Investor Notice Regarding Partial Amendments to the Articles of Incorporation
September 19, 2025
Pharma Foods International : September 11, 2025 Investor Consolidated Financial Results for the Fiscal Year Ended July 31, 2025 (Under Japanese GAAP)
September 11, 2025
Pharma Foods International : September 4, 2025 Investor Notice Regarding Execution of Loan Agreement with Financial Covenants
September 3, 2025
Pharma Foods International : August 19, 2025 Investor Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants
August 18, 2025
Pharma Foods International : July 16, 2025 Research and Development Pharma Foods’ Antibody Technology Advances as Takeda Exercises Sequence Purchase Option
July 15, 2025
Pharma Foods International : June 16, 2025 Investor Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants
June 16, 2025
Pharma Foods International : June 10, 2025 Investor Supplementary Materials of Consolidated Financial Results for the Nine Months Ended April 30, 2025
June 10, 2025
Pharma Foods International : June 10, 2025 Investor Consolidated Financial Results for the Nine Months Ended April 30, 2025 (Under Japanese GAAP)
June 10, 2025
Pharma Foods International : May 14, 2025 Investor Notice Concerning Results of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
May 13, 2025
Pharma Foods International : May 13, 2025 Investor Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
May 13, 2025
Pharma Foods International : February 12, 2025 Research and Development The establishment of World's first "CADASIL Drug Discovery Research Department" in collaboration with National Cerebral and Cardiovascular Center
February 11, 2025
Pharma Foods International : December 13, 2024 Investor (Delayed)Summary of Consolidated Financial Results for the Three Months Ended October 31, 2024 (Based on Japanese GAAP)
December 12, 2024
Pharma Foods International : September 30, 2024 Investor Notice of the 27th Annual General Meeting of Shareholders
September 29, 2024
Pharma Foods International : September 27, 2024 Investor (Delayed) Summary of Consolidated Financial Results for the Year Ended July 31, 2024 (Based on Japanese GAAP)
September 27, 2024